We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$356M
AUM Growth
+$16M
Cap. Flow
-$15.2M
Cap. Flow %
-4.28%
Top 10 Hldgs %
38.78%
Holding
163
New
6
Increased
24
Reduced
67
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.11M
2
ADBE icon
Adobe
ADBE
+$1.47M
3
CSCO icon
Cisco
CSCO
+$1.12M
4
INTC icon
Intel
INTC
+$582K
5
WPC icon
W.P. Carey
WPC
+$447K

Sector Composition

Rank Sector Weight
1 Technology 21.7%
2 Healthcare 15.65%
3 Consumer Discretionary 13.04%
4 Consumer Staples 12.86%
5 Financials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOK icon
151
Nokia
NOK
$51B
$163K 0.05%
29,275
-2,300
-7% -$12.8K
CRT
152
Cross Timbers Royalty Trust
CRT
$61.3M
$158K 0.04%
10,729
OPK icon
153
Opko Health
OPK
$985M
$53K 0.01%
15,270
-6,000
-28% -$31.9K
BABA icon
154
Alibaba
BABA
$293B
-1,330
Closed -$247K
BSV icon
155
Vanguard Short-Term Bond ETF
BSV
$44.7B
-2,979
Closed -$233K
ATHN
156
DELISTED
Athenahealth, Inc.
ATHN
-4,752
Closed -$756K

Similar funds

Fairfield, Bush & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Fairfield, Bush & Co held 163 positions worth $356M, up 4.7% from $340M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fairfield, Bush & Co withdrew a net $15.2M in Q3 2018, closing 4 positions and reducing 67 holdings. Its most notable exit was Athenahealth, Inc., an estimated $756K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fairfield, Bush & Co opened a new position in Adobe worth $1.54M.

  • Fairfield, Bush & Co's largest Q3 2018 buy was Adobe: 5,710 shares worth $1.54M.
  • Fairfield, Bush & Co added most to Apple in Q3 2018, an estimated $2.11M increase.
  • Fairfield, Bush & Co's biggest Q3 2018 reduction was Neogen, cutting an estimated $2.65M.
  • Fairfield, Bush & Co fully exited Athenahealth, Inc. in Q3 2018, selling an estimated $756K.
  • Fairfield, Bush & Co's ten largest holdings make up 39% of its $356M portfolio in Q3 2018.
  • Fairfield, Bush & Co opened 6 new positions and closed 4 in Q3 2018.
  • Fairfield, Bush & Co's portfolio value rose 4.7% quarter-over-quarter to $356M.

Based on Fairfield, Bush & Co's 13F filing for Q3 2018, filed 13 Nov 2018.